Vitamin D deficiency, smoking, and lung function in the normative aging study

American Journal of Respiratory and Critical Care Medicine

Volumn 186, Issue 7, 2012, Pages 616-621

  Lange, Nancy E ^a,b   Sparrow, David ^c   Vokonas, Pantel ^c   Litonjua, Augusto A ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Effect modification; Lung function decline; Smoking; Vitamin D; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGED; AGING; ARTICLE; BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SPIROMETRY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AGED; AGED, 80 AND OVER; AGING; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; PULMONARY VENTILATION; SMOKING; SPIROMETRY; VITAL CAPACITY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84867126678     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201110-1868OC     Document Type: Article

References (47)

1. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009;20:1807-1820.
2. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010;10:1-15.
3. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-281.
4. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest 2005;128:3792-3798. (Pubitemid 43062638)
5. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, Coolen J, Mathieu C, Decramer M, Lambrechts D. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65:215-220.
6. Schellenberg D, Pare PD, Weir TD, Spinelli JJ, Walker BA, Sandford AJ. Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med 1998;157:957-961.
7. Shen LH, Zhang XM, Su DJ, Yao SP, Yu BQ, Wang HW, Lu FZ. Association of vitamin D binding protein variants with susceptibility to chronic obstructive pulmonary disease. J Int Med Res 2010;38:1093-1098.
8. Wood AM, Simmonds MJ, Gough SC, Stockley RA. Variation in the vitamin D binding protein (gc) gene is associated with the presence of bronchiectasis in alpha-1-antitrypsin deficiency [abstract]. Am J Respir Crit Care Med 2008;178:A776.
9. Ito I, Nagai S, Hoshino Y, Muro S, Hirai T, Tsukino M, Mishima M. Risk and severity of COPD is associated with the group-specific component of serum globulin 1f allele. Chest 2004;125:63-70. (Pubitemid 38114565)
10. Hurst JR, Perera WR, Wilkinson TM, Donaldson GC, Wedzicha JA. Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006;173:71-78. (Pubitemid 43069790)
11. Sevenoaks MJ, Stockley RA. Chronic obstructive pulmonary disease, inflammation and co-morbidity: a common inflammatory phenotype? Respir Res 2006;7:70.
12. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease: oxidative stress study group. Am J Respir Crit Care Med 1997;156:341-357. (Pubitemid 27351964)
13. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001;429:195-207. (Pubitemid 33043996)
14. MacNee W, Rahman I. Is oxidative stress central to the pathogenesis of chronic obstructive pulmonary disease? Trends Mol Med 2001;7:55-62. (Pubitemid 33718642)
15. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [accessed 2010 Aug 30]. Available from: http://www.goldcopd.org/
16. Kuo YT, Kuo CH, Lam KP, Chu YT, Wang WL, Huang CH, Hung CH. Effects of vitamin D3 on expression of tumor necrosis factor-alpha and chemokines by monocytes. J Food Sci 2010;75:H200-H204.
17. Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A. 1alpha,25-dihydroxyvitamin D3 inhibits cd40l-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009;45:190-197.
18. Koli K, Keski-Oja J. 1alpha,25-Dihydroxyvitamin D3 and its analogues down-regulate cell invasion-associated proteases in cultured malignant cells. Cell Growth Differ 2000;11:221-229. (Pubitemid 30211011)
19. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 2007;77:47-57. (Pubitemid 46590467)
20. Hansdottir S, Monick MM, Lovan N. Powers LS, Hunninghake, GW. Smoking disrupts vitamin D metabolism in the lungs [abstract]. Am J Respir Crit Care Med 2010;181:A1425.
21. Haley KJ, Manoli SE, Tantisira KG, Litonjua AA, Nguyen P, Kobzik L, Weiss ST. Maternal smoking causes abnormal expression of the vitamin D receptor [abstract]. Am J Respir Crit Care Med 2009;179:A5874.
22. Kunisaki KM, Niewoehner DE, Singh RJ, Connett JE. Vitamin D status and longitudinal lung function decline in the lung health study. Eur Respir J 2011;37:238-243.
23. Lange NE, Sparrow D, Vokonas P, Litonjua AA. Vitamin D deficiency and obstructive lung disease in the normative aging study. Am J Respir Crit Care Med 2010;181:A1887.
24. Bell B, Rose C, Damon A. The normative aging study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev 1972;3:5-17.
25. Sparrow D, O'Connor G, Colton T, Barry CL, Weiss ST. The relationship of nonspecific bronchial responsiveness to the occurrence of respiratory symptoms and decreased levels of pulmonary function. The normative aging study. Am Rev Respir Dis 1987;135:1255-1260. (Pubitemid 18021517)
26. American Thoracic Society. Standardization of spirometry-1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285-1298.
27. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
28. Ersfeld DL, Rao DS, Body JJ, Sackrison JL Jr, Miller AB, Parikh N, Eskridge TL, Polinske A, Olson GT, MacFarlane GD. Analytical and clinical validation of the 25 OH vitamin D assay for the liaison automated analyzer. Clin Biochem 2004;37:867-874. (Pubitemid 39209026)
29. Wagner D, Hanwell HE, Vieth R. An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 2009;42:1549-1556.
30. Institute of Medicine: Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary reference intakes: calcium, vitamin D. Washington, DC: Institute of Medicine; 2010.
31. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981;123:659-664. (Pubitemid 11117589)
32. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: Time to act. Am J Respir Crit Care Med 2009;179:630-636.
33. Wright RJ. Make no bones about it: increasing epidemiologic evidence links vitamin D to pulmonary function and COPD. Chest 2005;128:3781-3783. (Pubitemid 43062632)
34. Quint JK, Wedzicha JA. Is vitamin D deficiency important in the natural history of COPD? Thorax 2010;65:192-194.
35. Forli L, Halse J, Haug E, Bjortuft O, Vatn M, Kofstad J, Boe J. Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med 2004;256:56-62. (Pubitemid 38813620)
36. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-390.
37. Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, Weiss ST, Litonjua AA. Serum vitamin D levels and severe asthma exacerbations in the childhood asthma management program study. J Allergy Clin Immunol 2010;126:52-58, e5.
38. Chinellato I, Piazza M, Sandri M, Peroni D, Piacentini G, Boner AL. Vitamin D serum levels and markers of asthma control in Italian children. J Pediatr 2011;158:437-441.
39. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med 2010;181:699-704.
40. Li F, Peng M, Jiang L, Sun Q, Zhang K, Lian F, Litonjua AA, Gao J, Gao X. Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma. Respiration 2011; 81: 469-475.
41. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002;57:847-852. (Pubitemid 35178607)
42. Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of nf-kappab-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol 2010;184:965-974.
43. Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL. Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med 2004;170:492-498. (Pubitemid 39209129)
44. Joos L, He JQ, Shepherdson MB, Connett JE, Anthonisen NR, Pare PD, Sandford AJ. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet 2002;11:569-576. (Pubitemid 34257493)
45. Song Y, Qi H, Wu C. Effect of 1,25-(OH)2D3 (a vitamin D analogue) on passively sensitized human airway smooth muscle cells. Respirology 2007;12:486-494. (Pubitemid 46961826)
46. Danilenko M, Wang Q, Wang X, Levy J, Sharoni Y, Studzinski GP. Carnosic acid potentiates the antioxidant and prodifferentiation effects of 1alpha,25-dihydroxyvitamin D3 in leukemia cells but does not promote elevation of basal levels of intracellular calcium. Cancer Res 2003;63:1325-1332. (Pubitemid 36348712)
47. Hanada K, Sawamura D, Nakano H, Hashimoto I. Possible role of 1,25-dihydroxyvitamin D3-induced metallothionein in photoprotection against UVB injury in mouse skin and cultured rat keratinocytes. J Dermatol Sci 1995;9:203-208.